AMRUTANJAN vs HALEOSLABS: Stock Comparison

Amrutanjan Health Care Limited vs Haleos Labs Limited

Live data: 22 July 2026, 3:07 PM IST • Source: NSE and company filings

Amrutanjan Health Care Limited is the larger company by market capitalisation. Amrutanjan Health Care Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Amrutanjan Health Care Limited and Haleos Labs Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, AMRUTANJAN is more favourable on 9 of 11 scored metrics and HALEOSLABS on 2These counts are context-free and are not an overall rating.

Amrutanjan Health Care Limited

Key Differences

Market Cap

AMRUTANJAN is the larger company

₹1,528 Cr vs ₹484 Cr

P/E Ratio

AMRUTANJAN has a lower P/E

26.9x vs 27.94x

P/B Ratio

HALEOSLABS has a lower P/B

2.27x vs 4.21x

EPS

HALEOSLABS has higher earnings per share

₹57.3 vs ₹20.01

Dividend Yield

AMRUTANJAN has a higher dividend yield

1.02% vs 0.1%

Revenue Growth (TTM YoY)

AMRUTANJAN has faster revenue growth

10.5% vs 0%

EPS Growth (TTM YoY)

AMRUTANJAN has faster EPS growth

6.7% vs 0%

ROE

AMRUTANJAN has a higher ROE

20% vs 8.44%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

Metric	AMRUTANJAN	HALEOSLABS
Sector	Healthcare	—
Industry	Pharmaceuticals	—

Price

Metric	AMRUTANJAN	HALEOSLABS
Live Price	₹529.6	₹1,522.4
Day Change	-1.67%	-3.09%
Volume	21,892	281
52-Week High	₹790.95	₹1,774
52-Week Low	₹486	₹1,181
Distance from 52W High	-33.04%	-14.18%

Valuation

Metric	AMRUTANJAN	HALEOSLABS
Market Cap	₹1,528 Cr	₹484 Cr
P/E Ratio	26.9x	27.94x
P/B Ratio	4.21x	2.27x
EPS	₹20.01	₹57.3
Book Value	₹128.04	₹706
Dividend Yield	1.02%	0.1%

Growth

Metric	AMRUTANJAN	HALEOSLABS
Revenue Growth (TTM YoY)	10.5%	0%
EPS Growth (TTM YoY)	6.7%	0%
Qtr Sales Growth	—	-15.7%
Qtr Profit Growth	—	-85.2%

Profitability & Leverage

Metric	AMRUTANJAN	HALEOSLABS
ROE	20%	8.44%
ROCE	31.4%	9.91%
Net Margin	11.52%	5.33%
Operating Margin	17.7%	13.4%
Debt to Equity	0.02x	0.52x

Shareholding

As of Jun 2026 • change vs previous quarter

Metric	AMRUTANJAN	HALEOSLABS
Promoter Holding	46.52%	72.11%
FII Holding	2.44%▲ 0.27 pp	0%
DII Holding	12.28%▼ 0.38 pp	0.31%▲ 0.01 pp
Public Holding	38.72%▲ 0.11 pp	27.58%▼ 0.02 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Amrutanjan Health Care Limited and Haleos Labs Limited.

Related Comparisons

Infosys vs TCS HDFC Bank vs ICICI Bank Axis Bank vs Kotak Mahindra Bank HCL Technologies vs Wipro Hindustan Unilever vs ITC Maruti Suzuki vs Tata Motors

Browse all stock comparisons →

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.